+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Genetic screening for macular dystrophies in patients clinically diagnosed with dry age-related macular degeneration



Genetic screening for macular dystrophies in patients clinically diagnosed with dry age-related macular degeneration



Clinical Genetics 94(6): 569-574



It can be clinically challenging to distinguish dry age-related macular degeneration (AMD) from AMD-mimicking dystrophies, and sometimes misdiagnosis occurs. With upcoming therapies for dry AMD it is important to exclude patients with a different retinal disease from clinical trials. In this study we evaluated the occurrence of AMD-mimicking dystrophies in an AMD cohort. Whole-exome sequencing (WES) was performed in 218 patients with intermediate AMD or geographic atrophy secondary to AMD and 133 control individuals. WES data was analyzed for rare variants in 19 genes associated with autosomal dominant and recessive macular dystrophies mimicking AMD. In three (1.4%) of 218 cases we identified a pathogenic heterozygous variant (PRPH2 c.424C > T; p.R142W) causal for autosomal dominant central areolar choroidal dystrophy (CACD). Phenotypically, these patients all presented with geographic atrophy. In 12 (5.5%) of 218 cases we identified a heterozygous variant of unknown clinical significance, but predicted to be highly deleterious, in genes previously associated with autosomal dominant macular dystrophies. The distinction between AMD and AMD-mimicking dystrophies, such as CACD, can be challenging based on fundus examination alone. Genetic screening for genes associated with macular dystrophies, especially PRPH2, can be beneficial to help identify AMD-mimicking dystrophies.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 065795044

Download citation: RISBibTeXText

PMID: 30215852

DOI: 10.1111/cge.13447


Related references

Progress in the genetics of hereditary macular dystrophies and age-related macular degeneration. European Journal of Human Genetics 8(Suppl. 1): 32, 2000

Genetics of macular dystrophies and implications for age-related macular degeneration. Developments in Ophthalmology 37: 155-169, 2003

Macular dystrophies mimicking age-related macular degeneration. Progress in Retinal and Eye Research 39: 23-57, 2014

Durable recovery of the macular architecture and functionality of a diagnosed age-related macular degeneration 1 year after a single intravitreal injection of dobesilate. Bmj Case Reports 2013:, 2013

Visual acuity and contrast sensitivity in patients with neovascular age-related macular degeneration. Results from the Radiation Therapy for Age-Related Macular Degeneration (RAD-) Study. Graefe's Archive for Clinical and Experimental Ophthalmology 241(12): 968-974, 2003

Development of typical age-related macular degeneration and polypoidal choroidal vasculopathy in fellow eyes of Japanese patients with exudative age-related macular degeneration. American Journal of Ophthalmology 146(1): 96, 2008

Use of buccal swab as a source of genomic DNA for genetic screening in patients with age-related macular degeneration. Chinese Journal of Ophthalmology 48(2): 114-118, 2012

Re: Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group, et al.: Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials (Ophthalmology 2016;123:1751-1761). Ophthalmology 124(3): E31-E32, 2017

Macular function in eyes with early age-related macular degeneration with or without contralateral late age-related macular degeneration. Retina 27(7): 879-890, 2007

Questioning Macular Pigment Measurement Methods and Genetic Risk of Age-Related Macular Degeneration. JAMA Ophthalmology 136(4): 453, 2018

Japanese age-related macular degeneration trial: 1-year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration. American Journal of Ophthalmology 136(6): 1049-1061, 2003

Macular and multifocal electroretinography in the evaluation of the retinal macular region function in age-related macular degeneration. Vestnik Oftalmologii 125(1): 27-32, 2009

Macular Atrophy and Macular Morphology in Aflibercept-Treated Neovascular Age-Related Macular Degeneration. Retina 38(9): 1743-1750, 2018

Recovery of the neurosensory retina after macular translocation surgery is independent of preoperative macular sensitivity in neovascular age-related macular degeneration. Retina 31(8): 1637-1649, 2011

Impact of fluorescein angiographic characteristics of macular lesions on outcomes after macular translocation 360 degree surgery in eyes with age-related macular degeneration. Retina 25(5): 597-607, 2005